Weizmann Institute of Science
OrganisationROR
People
Professor, 7 Apr 2025, reporter.nih.gov
Trials
Collaborator, Phase 1, Completed, 2021, 3 people, 24 Mar 2021, clinicaltrials.gov
The Role of the Microbiome in the Response to Dietary Fibers Intake During Intermittent Fasting
No phase, Active, not recruiting, 2021, 115 people, 18 Nov 2020, clinicaltrials.gov
Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
Collaborator, No phase, Completed, 2018, 138 people, 15 Jun 2018, clinicaltrials.gov
Grants and prizes
HORIZON-ERC-POC, A peptide targeting p21-CDK4 interaction for treatment of pulmonary fibrosis, 101268383, €150k, 2026–2027, 9 Feb 2026, cordis.europa.eu
HORIZON-ERC-POC, ACHIEVE: Development of an oral ACG-based treatment to combat obesity, maintain long-term dieting success and improve metabolic health, 101247823, €150k, 2025–2027, 25 Aug 2025, cordis.europa.eu
U01, Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort, U01CA279001, US$179.8k, 2023–2027, 7 Apr 2025, reporter.nih.gov
ERC-COG, Understanding Diagnosing and Early intervention in the Myeloid malignancy Continuum, 101170843, €2m, 2025–2030, 6 Feb 2025, cordis.europa.eu
ERC-STG, Uncovering the molecular mechanisms of oligodendrocyte plasticity in cognitive aging., 101163696, €1.5m, 2024–2029, 22 Aug 2024, cordis.europa.eu
HORIZON-EIC, Glucose variability patterns for precision nutrition in diabetes, 101161509, €819.1k, 2024–2028, 3 Jun 2024, cordis.europa.eu